• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

    4.640 -0.060 (-1.28%)
    Streaming Delayed Price Updated: 3:25 PM EST, Jan 9, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 12,742,076
    Open 4.780
    Bid (Size) 4.640 (27,500)
    Ask (Size) 4.650 (11,700)
    Prev. Close 4.700
    Today's Range 4.620 - 4.815
    52wk Range 3.790 - 12.36
    Shares Outstanding 168,425,907
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    The $3 Billion Bet: How Isomorphic Labs is Rewriting the Rules of Drug Discovery with Eli Lilly and Novartis
    In a move that has fundamentally reshaped the landscape of the pharmaceutical industry, Isomorphic Labs—the London-based drug discovery arm of Alphabet Inc. (NASDAQ: GOOGL)—has solidified its position... 
    Via TokenRing AI
    Topics Artificial Intelligence

    Performance

    YTD
    +10.5%
    +10.5%
    1 Month
    -2.7%
    -2.7%
    3 Month
    -21.5%
    -21.5%
    6 Month
    -18.8%
    -18.8%
    1 Year
    -36.1%
    -36.1%

    More News

    Read More
    News headline image
    The Great Unlocking: How AlphaFold 3’s Open-Source Pivot Sparked a New Era of Drug Discovery
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    Forget Recursion Pharmaceuticals Stock. This Is a Much Better Buy. ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Cathie Wood’s Strategic Pivot: Ark Invest Trims Tesla Holdings to Fuel AI and Crypto Bets Ahead of 2026
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Myseum (NASDAQ: MYSE) Ignites “Picture Party,” a New Era in Social Media on All Apple (NASDAQ: AAPL) Devices Now! more stocks inside…
    Via AB Newswire
    Topics Artificial Intelligence
    Why Recursion Pharmaceuticals Stock Vaulted 11% Higher on Wednesday ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Recursion Pharmaceuticals Stock Is Soaring Today: Here's Why ↗
    Via Benzinga
    News headline image
    Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks Making The Biggest Moves Today ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Stocks
    News headline image
    Why Recursion Pharamaceuticals Topped the Market Today ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
    From Recursion Pharmaceuticals, Inc.
    Via GlobeNewswire
    News headline image
    Jim Cramer: This Health Care Stock Has Been 'Horrendous' ↗
    Via Benzinga
    News headline image
    10 AI Stocks Worth Buying Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
    Via MarketMinute
    Topics Artificial Intelligence Death Intellectual Property
    News headline image
    Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
    Via TokenRing AI
    Topics Artificial Intelligence Economy Emissions
    News headline image
    Recursion Announces Webinar For Upcoming Clinical Data Readout on the TUPELO Phase 1b/2 Trial of REC-4881 in Familial Adenomatous Polyposis on December 8, 2025
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    popEVE AI: Harvard-Developed Model Set to Revolutionize Rare Disease Diagnosis and Drug Discovery
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock? ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Is Recursion Pharmaceuticals a Meme Stock? ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
    From MarketNewsUpdates.com
    Via GlobeNewswire
    News headline image
    Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
    Via MarketMinute
    Topics Artificial Intelligence Economy Intellectual Property
    News headline image
    Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
    Via FinancialNewsMedia
    News headline image
    Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock ↗
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    News headline image
    AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
    Via TokenRing AI
    Topics Artificial Intelligence Climate Change Intellectual Property
    News headline image
    Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes
    Via MarketMinute
    Topics Artificial Intelligence Economy Law Enforcement

    Frequently Asked Questions

    Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
    Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
    What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
    What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 4.640
    When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
    The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 01/09/26 03:25 PM ET
    What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 781.50M
    How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock has 781M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.